The amount of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia.

被引：0
|
作者：
Venditti, A [1 ]
Buccisano, F [1 ]
Tamburini, A [1 ]
Del Poeta, G [1 ]
Maurillo, L [1 ]
Del Moro, B [1 ]
Epiceno, AM [1 ]
Amadori, S [1 ]
机构：
[1] Univ Rome Tor Vergata, Rome, Italy
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3074
引用
收藏
页码：695A / 695A
页数：1
相关论文
共 50 条
  • [1] Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia
    Venditti, A
    Buccisano, F
    Del Poeta, G
    Maurillo, L
    Tamburini, A
    Cox, C
    Battaglia, A
    Catalano, G
    Del Moro, B
    Cudillo, L
    Postorino, M
    Masi, M
    Amadori, S
    [J]. BLOOD, 2000, 96 (12) : 3948 - 3952
  • [2] Detection of minimal residual disease in acute myeloid leukemia.
    Baer M.R.
    [J]. Current Oncology Reports, 2002, 4 (5) : 398 - 402
  • [3] Tryptase as a novel marker of minimal residual disease in acute myeloid leukemia.
    Sperr, WR
    Mitterbauer, M
    Mitterbauer, G
    Jaeger, U
    Lechner, K
    Valent, P
    [J]. BLOOD, 2001, 98 (11) : 107A - 107A
  • [4] Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome
    B Gruhn
    S Hongeng
    H Yi
    ML Hancock
    JE Rubnitz
    GAM Neale
    GR Kitchingman
    [J]. Leukemia, 1998, 12 : 675 - 681
  • [5] Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome
    Gruhn, B
    Hongeng, S
    Yi, H
    Hancock, ML
    Rubnitz, JE
    Neale, GAM
    Kitchingman, GR
    [J]. LEUKEMIA, 1998, 12 (05) : 675 - 681
  • [6] Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia
    Buccisano, Francesco
    Maurillo, Luca
    Del Principe, Maria Ilaria
    Di Veroli, Ambra
    De Bellis, Eleonora
    Biagi, Annalisa
    Zizzari, Annagiulia
    Rossi, Valentina
    Rapisarda, Vito
    Amadori, Sergio
    Voso, Maria Teresa
    Lo-Coco, Francesco
    Arcese, William
    Venditti, Adriano
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (04) : 307 - 313
  • [7] Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy
    Sebastian Schwind
    Madlen Jentzsch
    Enrica Bach
    Sebastian Stasik
    Christian Thiede
    Uwe Platzbecker
    [J]. Current Treatment Options in Oncology, 2020, 21
  • [8] Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy
    Schwind, Sebastian
    Jentzsch, Madlen
    Bach, Enrica
    Stasik, Sebastian
    Thiede, Christian
    Platzbecker, Uwe
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (01)
  • [9] Clinical implications of immunological detection of minimal residual disease in acute myeloid leukemia.
    Venditti, A
    Buccisano, F
    Tamburini, A
    Del Poeta, G
    Maurillo, L
    Battaglia, A
    Del Moro, B
    Epiceno, AM
    Aronica, G
    Amadori, S
    [J]. BLOOD, 1998, 92 (10) : 79A - 79A
  • [10] WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidation
    Gray, James X.
    McMillen, Lyle
    Mollee, Peter
    Paul, Sanjoy
    Lane, Steven
    Bird, Robert
    Gill, Devinder
    Saal, Russell
    Marlton, Paula
    [J]. LEUKEMIA RESEARCH, 2012, 36 (04) : 453 - 458
12345